MedPath

IMPACT Youth Study - Physical activity for young people with depression: A cluster randomised controlled trial to test the effectiveness of incorporating a brief intervention into routine clinical care.

Not Applicable
Completed
Conditions
Depression
Mental Health - Depression
Registration Number
ACTRN12614000772640
Lead Sponsor
Orygen, The National Centre of Excellence in Youth Mental Health
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
472
Inclusion Criteria

As this is a pragmatic effectiveness trial, selection into the study will be based on ‘real-world’ characteristics of young people with depression: a) meeting the requirements for a Mental Health Treatment Plan (MHTP) to access psychological treatment under the Medicare Benefits Scheme Better Access program or Access to Allied Psychological Services (ATAPS) with likely diagnoses of major depressive disorder, rather than by a formal diagnostic research interview; and b) a score on the clinician-rated Quick Inventory of Depression Symptoms - Adolescent Version of 11 or greater, indicating depression levels of moderate or above.

Exclusion Criteria

Presence of a psychotic disorder meeting diagnostic threshold during the intake assessment upon first presentation to the headspace centre; current physical activity meeting the Australian Government Guidelines (under 18 years: 60 mins/day moderate-vigorous activity; over 18 years: 30 mins moderate physical activity, most or all days); presence of an eating disorder meeting diagnostic threshold assessed during the standard intake procedure at headspace centres, using a standardised psychosocial assessment; organic mental disorder; physical illness that contra-indicates participation in physical activity; intellectual disability/cognitive impairment that precludes providing informed consent. Any young person reporting a prior history of physical illness which might impede their ability to take part in physical activity will be required to receive medical clearance from a GP in order to partake in the trial.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
evel of depression symptoms at post-treatment measured by the 17-item clinician-rated Quick Inventory of Depression Symptoms - Adolescent Version (QIDS-A17-C).[Change in QIDS-A17-C scores, between baseline and end of study intervention (between 4-10 sessions). ]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath